Optimal approach to potentially resectable liver metastases from colorectal cancer

被引:4
作者
Falcone, Alfredo [1 ,2 ]
Fornaro, Lorenzo [1 ]
Loupakis, Fotios [1 ]
Masi, Gianluca [1 ]
Vasile, Enrico [1 ]
机构
[1] Ist Toscano Tumori, Dept Oncol, Azienda Livorno USL6, Livorno, Italy
[2] Univ Pisa, Dept Oncol Transplants & New Technol Med, I-56100 Pisa, Italy
关键词
D O I
10.1586/14737140.8.10.1533
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1533 / 1539
页数:7
相关论文
共 51 条
[21]  
GARUFI C, 2008, 2008 GASTR CANC S 25
[22]   Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer [J].
Giacchetti, S ;
Perpoint, B ;
Zidani, R ;
Le Bail, N ;
Faggiuolo, R ;
Focan, C ;
Chollet, P ;
Llory, JF ;
Letourneau, Y ;
Coudert, B ;
Bertheaut-Cvitkovic, F ;
Larregain-Fournier, D ;
Le Rol, A ;
Walter, S ;
Adam, R ;
Misset, JL ;
Lévi, F .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :136-147
[23]   The continuum of care: A paradigm for the management of metastatic colorectal cancer [J].
Goldberg, Richard M. ;
Rothenberg, Mace L. ;
Van Cutsem, Eric ;
Benson, Al B., III ;
Blanke, Charles D. ;
Diasio, Robert B. ;
Grothey, Axel ;
Lenz, Heinz-Josef ;
Meropol, Neal J. ;
Ramanathan, Ramesh K. ;
Becerra, Carlos H. Roberto ;
Wickham, Rita ;
Armstrong, Delma ;
Viele, Carol .
ONCOLOGIST, 2007, 12 (01) :38-50
[24]   A Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer [J].
Goldberg, RM ;
Sargent, DJ ;
Morton, RF ;
Fuchs, CS ;
Ramanathan, RK ;
Williamson, SK ;
Findlay, BP ;
Pitot, HC ;
Alberts, SR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (01) :23-30
[25]   Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer [J].
Gruenberger, Brigit ;
Tamandl, Dietmar ;
Schueller, Johannes ;
Scheithauer, Werner ;
Zielinski, Christoph ;
Herbst, Friedrich ;
Gruenberger, Thomas .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (11) :1830-1835
[26]   Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].
Hurwitz, H ;
Fehrenbacher, L ;
Novotny, W ;
Cartwright, T ;
Hainsworth, J ;
Heim, W ;
Berlin, J ;
Baron, A ;
Griffing, S ;
Holmgren, E ;
Ferrara, N ;
Fyfe, G ;
Rogers, B ;
Ross, R ;
Kabbinavar, F .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342
[27]   Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab [J].
Ince, WL ;
Jubb, AM ;
Holden, SN ;
Holmgren, EB ;
Tobin, P ;
Sridhar, M ;
Hurwitz, HI ;
Kabbinavar, F ;
Novotny, WF ;
Hillan, KJ ;
Koeppen, H .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (13) :981-989
[28]   Presurgical chemotherapy in patients being considered for liver resection [J].
Kemeny, Nancy .
ONCOLOGIST, 2007, 12 (07) :825-839
[29]   Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer:: European Organisation for Research and Treatment of Cancer Gastrointestinal Group study 40986 [J].
Köhne, CH ;
van Cutsem, E ;
Wils, J ;
Bokemeyer, C ;
El-Serafi, M ;
Lutz, MP ;
Lorenz, M ;
Reichardt, P ;
Rückle-Lanz, H ;
Frickhofen, N ;
Fuchs, R ;
Mergenthaler, HG ;
Langenbuch, T ;
Vanhoefer, U ;
Rougier, P ;
Voigtmann, R ;
Müller, L ;
Genicot, B ;
Anak, Ö ;
Nordlinger, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :4856-4865
[30]   Whole-body MR imaging: Evaluation of patients for metastases [J].
Lauenstein, TC ;
Goehde, SC ;
Herborn, CU ;
Goyen, M ;
Oberhoff, C ;
Debatin, JF ;
Ruehm, SG ;
Barkhausen, J .
RADIOLOGY, 2004, 233 (01) :139-148